Novel Therapies Targeting Kidney Disease


Latest Press Releases
Press releases
  • 16 Dec 2025  ·  Regulatory information

    Guard Therapeutics presents the Nomination Committee for 2026

    Read more
  • 08 Dec 2025

    Guard Therapeutics appoints Redeye as financial advisor in the strategic review

    Read more
  • 05 Dec 2025  ·  Regulatory information

    Guard Therapeutics changes Certified Adviser to Redeye AB

    Read more
  • 04 Dec 2025  ·  Regulatory information

    Guard Therapeutics Explores Strategic Alternatives

    Read more
Show more
In focus
  • 16 Sep 2025 / Presentation

    CEO Tobias Agervald appears on BiotechTV

    Read more
  • 17 Oct 2024 / Presentation

    Guard presents at Redeye Theme "Cardiovascular & Metabolic Diseases Event 2024"

    Read more
  • 23 Sep 2024 / Presentation

    CEO Tobias Agervald appears on BiotechTV

    Read more
  • 19 Sep 2024 / Presentation

    Presentation at Pareto Securities' 15th Annual Healthcare Conference

    Read more
Show more
Upcoming events
  • 20 Feb 2026

    Year-end Report 2025

    Read more
  • 20 Apr 2026

    Annual Report 2025 (approximate date)

    Read more
  • 11 May 2026

    Interim Report January–March 2026

    Read more
  • 18 May 2026

    Annual General Meeting 2026

    Read more
Event calendar/Financial calendar